| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226802 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
In our experience, using IMRT to treat NSCLC leads to low rates of pulmonary and esophageal toxicity, and favorable clinical outcomes in terms of survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Zhi-Qin M.D., Ph.D., Kunyu M.D., Ritsuko M.D., Xiong M.D., Susan L. Ph.D., Yan M.D., Mary K. Ph.D., Sastray Ph.D., Peter Ph.D., Guangying M.D., Daniel M.D., Charles M.D., Radhe Ph.D., James D. M.D., Zhongxing M.D.,